KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amneal Pharmaceuticals (AMRX) Tax Rate (2017 - 2025)

Historic Tax Rate for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Q3 2025 value amounting to 447.16%.

  • Amneal Pharmaceuticals' Tax Rate rose 4233900.0% to 447.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 16.13%, marking a year-over-year increase of 351100.0%. This contributed to the annual value of 34.36% for FY2024, which is 132500.0% down from last year.
  • Per Amneal Pharmaceuticals' latest filing, its Tax Rate stood at 447.16% for Q3 2025, which was up 4233900.0% from 31.14% recorded in Q2 2025.
  • Amneal Pharmaceuticals' 5-year Tax Rate high stood at 447.16% for Q3 2025, and its period low was 198.19% during Q3 2021.
  • For the 5-year period, Amneal Pharmaceuticals' Tax Rate averaged around 28.17%, with its median value being 2.68% (2021).
  • Per our database at Business Quant, Amneal Pharmaceuticals' Tax Rate surged by 8133300bps in 2021 and then crashed by -2201600bps in 2023.
  • Over the past 5 years, Amneal Pharmaceuticals' Tax Rate (Quarter) stood at 25.12% in 2021, then skyrocketed by 194bps to 23.51% in 2022, then plummeted by -151bps to 11.9% in 2023, then plummeted by -200bps to 35.64% in 2024, then skyrocketed by 1355bps to 447.16% in 2025.
  • Its Tax Rate stands at 447.16% for Q3 2025, versus 31.14% for Q2 2025 and 34.33% for Q1 2025.